Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA081212-02
Application #
6174339
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Patel, Appasaheb1 R
Project Start
1999-04-05
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
2
Fiscal Year
2000
Total Cost
$145,068
Indirect Cost

  Institution

Name
New York University
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016

  Publications

Clendenen, Tess V; Hertzmark, Kathryn; Koenig, Karen L et al. (2016) Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study. Horm Cancer 7:178-87
Clendenen, Tess V; Rendleman, Justin; Ge, Wenzhen et al. (2015) Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology. PLoS One 10:e0135943
Clendenen, Tess; Zeleniuch-Jacquotte, Anne; Wirgin, Isaac et al. (2013) Genetic variants in hormone-related genes and risk of breast cancer. PLoS One 8:e69367
Lundin, Eva; Wirgin, Isaac; Lukanova, Annekatrin et al. (2012) Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol 36:445-52
Zeleniuch-Jacquotte, A; Shore, R E; Afanasyeva, Y et al. (2011) Postmenopausal circulating levels of 2- and 16ýý-hydroxyestrone and risk of endometrial cancer. Br J Cancer 105:1458-64
Zeleniuch-Jacquotte, Anne; Lundin, Eva; Micheli, Andrea et al. (2006) Circulating enterolactone and risk of endometrial cancer. Int J Cancer 119:2376-81
Lukanova, Annekatrin; Zeleniuch-Jacquotte, Anne; Lundin, Eva et al. (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262-8
Lukanova, Annekatrin; Lundin, Eva; Micheli, Andrea et al. (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425-32